Periophil Biphasic
Bone Grafting Material, Synthetic. 510(k) K092788, from Cytophil, Inc. (East Troy, WI). Product code LYC, class 2.
As of Nov 19, 2026, K092788 is an FDA 510(k) held by Cytophil, Inc., substantially equivalent on Dec 18, 2009 after 99 days, with 1 recall tied to it in FDA's recall database.
- Review time: 99 days
- Recalls: 1
Periophil Biphasic is intended for use as a bone grafting material to fill, augment, or reconstruct periodontal or oral/maxillofacial defects. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. Periophil Biphasic can be used with autogenous bone grafting materials.
- MbcpK051885 · Biomatlante · Sep 16, 2005
| Started | Recall | Status |
|---|---|---|
| Jan 11, 2012 | Z-1012-2012Cytophil Corporation is recalling Periophil Biphasic Periophil Biphasic, Periobase Biphasic, and Periobone Biphasic because devices were inadvertently shipped after receiving an inadequate dose of radiation and this… | Terminated |
- Cytrans™ ElashieldK253317 · GC America, Inc. · Jul 6, 2026
- Bonalive MaxillofacialK253883 · Bonalive , Ltd. · May 14, 2026
- Bontree PlusK251818 · Hudens Bio Co., Ltd. · Mar 6, 2026
- FG Bone Graft MK244006 · Full Golden Biotech Co., Ltd. · Sep 17, 2025
- FG Bone Graft BK243745 · Full Golden Biotech Corporation · Aug 29, 2025
- Synthetic Bone Graft ParticulateK241186 · Shenzhen Dazhou Medical Technology Co., Ltd. · Feb 21, 2025
- CMFlexTMK213260 · Dimension Inx Corp. · Dec 30, 2022
- InRoad® Dental Synthetic Bone GraftK202675 · Osteogene Tech Corp · Mar 4, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 10, 2009
- Review panel
- Dental
- Regulation
- 21 CFR 872.3930
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files